MORGAN STANLEY PLC/CALL/STRYKER CORP./480/0.1/20.06.25 Stock

Warrant

DE000ME9BQM9

Market Closed - Börse Stuttgart 02:11:55 2024-05-10 pm EDT
0.36 EUR -2.70% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./480/0.1/20.06.25
1 month-49.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-10 0.36 -2.70% 0
24-05-09 0.37 -2.63% 0
24-05-08 0.38 +5.56% 0
24-05-07 0.36 +5.88% 0
24-05-06 0.34 -5.56% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 02:11 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME9BQM
ISINDE000ME9BQM9
Date issued 2024-02-27
Strike 480 $
Maturity 2025-06-20 (405 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.12
Lowest since issue 0.33
Spread 0.04
Spread %10.00%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW